Has Nicholas Bremer, MD received payments from drug or device companies?

Yes. Drug and device makers reported $81,888 in general payments to Nicholas Bremer, MD across 501 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nicholas Bremer, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nicholas Bremer, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nicholas Bremer, MD

Pain Medicine · Fernandina Beach, FLNPI 1083778468

Payments from drug & device makers

$81,888in general payments, 2019–2025

Across 501 payments — averaging $163.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$53K
Boston Scientific$11K
Medtronic$6K
Flowonix Medical Incorporated$5K
Stryker$1K
Nalu Medical, Inc.$1K
plus $5K from 34 others

$18in research payments, 2019–2025

Across 1 payment — averaging $17.87 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Saluda Medical Americas, Inc.$18

What the payments were for

Consulting fees$31,59648%
Speaking & faculty fees$2,8004%
Travel & lodging$13,34220%
Food & beverage$15,48723%
Education$2210%
Entertainment$2,7434%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	219	$53,042
Boston Scientific	89	$10,997
Medtronic(2 entities)	56	$5,799
Flowonix Medical Incorporated	2	$4,919
Stryker	7	$1,369
Nalu Medical, Inc.	8	$1,057
SPR Therapeutics, Inc	11	$746
Saluda Medical Americas, Inc.	12	$590
Curonix LLC	9	$462
Stimwave Technologies Incorporated	9	$458
AbbVie	17	$367
Amgen	10	$222
Globus Medical	1	$168
Vertos Medical, Inc.	8	$154
Interventional Pain Technologies Inc.	1	$146
Brixton Biosciences, Inc.	1	$138
Averitas Pharma Inc.	2	$130
Relievant Medsystems, Inc.	1	$129
Painteq LLC	2	$128
Camber Spine Technologies LLC	1	$117
Novartis	6	$106
Genesys Orthopedics Systems, L.L.C.	1	$68
Biohaven Pharmaceuticals, Inc.	2	$61
Pfizer	3	$50
Redhill Biopharma Inc.	2	$45
Johnson & Johnson	2	$43
Scilex Pharmaceuticals Inc.	2	$43
Biotronik NRO, Inc.	2	$42
Bioventus LLC	2	$41
Amneal Pharmaceuticals LLC	2	$34
Vertiflex, Inc.	1	$29
Nevro Corp.	2	$28
Sonex Health, Inc.	1	$26
Vertex	1	$26
Lundbeck LLC	1	$24
Convatec Inc.	1	$17
Virtus Pharmaceuticals LLC	1	$16
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$16
Si-bone, Inc.	1	$16
IBSA Pharma Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Neuromodulation Dspsbls and Accs$17,340
Proclaim Family of SCS IPGs$11,983
GENERAL PAIN MANAGEMENT$6,712
Prometra II$4,919
PROCLAIM$3,338
INTELLIS ADAPTIVESTIM$1,573
KYPHON EXPRESS II KYPHOPAK TRAY$1,417
SPECTRA WAVEWRITER$1,295
IVS - VERTEBRAL AUGMENTATION PRODUCTS$1,143
Nalu Neurostimulation System$931
INTELLIS$850
NA$555
SPRINT PNS System$500
GENERAL - THERAPIES$386
KYPHON Balloon Kyphoplasty$367
Axium$341
Evoke$282
ETERNA$279
Intracept$258
PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$256

How this compares

$81,888 in reported general payments places this provider in the 95th percentile of 596 pain medicine providers in Florida.

See all pain medicine providers in Florida →

Medicare billing

Part B allowed, 2024

$427,663

Medicare patients

328

Services billed

3,632

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	596	$18,138
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	389	$9,466
Pregabalin	209	$5,440
Gabapentin	144	$3,135
Oxycodone Hcl	132	$1,680
Tizanidine Hcl	76	$1,294
Tramadol Hcl	182	$1,233
Buprenorphine Hcl	35	$1,140
Acetaminophen-CodeineAcetaminophen With Codeine	24	$865
Baclofen	46	$818
Amitriptyline Hcl	40	$619
Lidocaine	12	$528
Morphine Sulfate ErMorphine Sulfate	22	$522
Duloxetine Hcl	24	$487
Morphine Sulfate	15	$292

Paid to pharmacies, not to this prescriber.

Other pain medicine in Fernandina Beach

Anand PatelOrmond Beach$20.4M
Julio PaezClermont$2.3M
Joseph PergolizziNaples$2.1M
Abel MurilloMiami$1.6M
George MonluxPalm Coast$1.3M
Ferdinand FormosoJacksonville$1M
Cesar LassalleOrlando$1M
Robert GuirguisTampa$895K
Ashraf HannaClearwater$608K
Peter MichaelCoral Gables$496K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →